Anzeige
Erschienen in:
01.10.2014 | Short Communication
PNPLA3 variant I148M is associated with altered hepatic lipid composition in humans
Erschienen in: Diabetologia | Ausgabe 10/2014
Einloggen, um Zugang zu erhaltenAbstract
Aims/hypothesis
The common sequence variant I148M of the patatin-like phospholipase domain-containing protein 3 gene (PNPLA3) is associated with increased hepatic triacylglycerol (TAG) content, but not with insulin resistance, in humans. The PNPLA3
I148M variant was previously reported to alter the specificity of the encoded enzyme and subsequently affect lipid composition.
Methods
We analysed the fatty acid composition of five lipid fractions from liver tissue samples from 52 individuals, including 19 carriers of the minor PNPLA3
I148M variant.
Results
PNPLA3
I148M was associated with a strong increase (1.75-fold) in liver TAGs, but with no change in other lipid fractions. PNPLA3
I148M minor allele carriers had an increased n-3 polyunsaturated fatty acid (PUFA) α-linolenic acid content and reductions in several n-6 PUFAs in the liver TAG fraction. Furthermore, there was a strong inverse correlation between n-6 PUFA and TAG content independent of PNPLA3 genotype. In a multivariate model including liver fat content, PNPLA3 genotype and fatty acid composition, two significant differences could be exclusively attributed to the PNPLA3
I148M minor allele: reduced stearic acid and increased α-linolenic acid content in the hepatic TAG fraction.
Conclusions
These changes therefore suggest a mechanism to explain the PNPLA3
I148M-dependent increase in liver fat content without causing insulin resistance. Stearic acid can induce insulin resistance, whereas α-linolenic acid may protect against it.